Detalles de la búsqueda
1.
Cost-effectiveness analysis of pembrolizumab compared to standard of care as first line treatment for patients with advanced melanoma in Hong Kong.
Cost Eff Resour Alloc
; 18: 2, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31969794
2.
Economic analysis of aprepitant-containing regimen to prevent chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Hong Kong.
Asia Pac J Clin Oncol
; 10(1): 80-91, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24571059
Resultados
1 -
2
de 2
1
Próxima >
>>